Medically reviewed by Brendan Camp, MD Psoriasis is a skin condition that causes patches of inflamed, scaly, flaky skin. It's most likely to affect your elbows, knees, or scalp, but psoriasis can ...

I would have had no clue what a "bleph" was. Now, it's something that my friends and I regularly reference wanting, (half) jokingly, in casual conversation. In case you're not quite as vain as we are: ...

This constellation of findings resulted in multiple concurrent diagnoses: rosacea-associated evaporative dry eye, moderate meibomian gland dysfunction with poor expression, Demodex blepharitis, ...

LONDON, GREATER LONDON, UNITED KINGDOM, July 4, 2025 /EINPresswire.com/ -- The blepharitis market has seen rapid growth in recent years. The market size is forecasted to grow from $0.86 billion in ...

TARS can expand lotilaner beyond Demodex blepharitis, with trials set to initiate in H2'25 in ocular rosacea and 2026 for Lyme disease prevention.

Eye mites are also more common in people who wear contact lenses and people with rosacea, blepharitis or diabetes. Diagnosis and treatment ...

XDEMVY (lotilaner ophthalmic solution) 0.25%, formerly known as TP-03, is a novel prescription eye drop designed to treat Demodex blepharitis by targeting and eradicating the root cause of the ...

Tarsus Pharmaceuticals plans to initiate a Phase 2 study for TP-04, targeting Ocular Rosacea treatment. Quiver AI Summary Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an ...

Ocular Rosacea (OR) is a highly prevalent, undertreated eye disease with no FDA-approved therapy. It affects ~15-18 million Americans, and more than half of all cases are caused by an infestation ...

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned ...